Moleculin Biotech, Inc.

Moleculin Biotech, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. Moleculin Biotech, Inc. could be a weak company given it's low Piotroski F-score. The momentum for this stock is not very good. Moleculin Biotech, Inc. is not very popular among insiders. Moleculin Biotech, Inc. is a mediocre stock to choose.

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company, which focuses on the development...

News

Moleculin Biotech (NASDAQ:MBRX) Receives New Coverage from Analysts at StockNews.com

Ticker Report StockNews.com began coverage on shares of Moleculin Biotech (NASDAQ:MBRX - Free Report) in a report released on Tuesday morning. The firm issued a sell rating on the stock. Moleculin Biotech Price...\n more…

Moleculin Announces First Patients Treated in Phase 2 Clinical Trial of STAT3 Inhibitor in Combination with Radiation for the Treatment of Glioblastoma

PR Newswire Moleculin Announces First Patients Treated in Phase 2 Clinical Trial of STAT3 Inhibitor in Combination with Radiation for the Treatment of Glioblastoma Moleculin Announces First Patients Treated in...\n more…

Moleculin to Present at the H.C. Wainwright 26th Annual Global Investment Conference

PR Newswire Moleculin to Present at the H.C. Wainwright 26th Annual Global Investment Conference Moleculin to Present at the H.C. Wainwright 26th Annual Global Investment Conference PR Newswire HOUSTON, Sept. 3...\n more…

Moleculin Biotech (NASDAQ:MBRX) Coverage Initiated by Analysts at StockNews.com

Ticker Report StockNews.com initiated coverage on shares of Moleculin Biotech (NASDAQ:MBRX - Free Report) in a research note issued to investors on Monday morning. The brokerage issued a sell rating on the stock...\n more…

Moleculin to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar

PR Newswire Moleculin to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar Moleculin to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar PR Newswire...\n more…

Moleculin Biotech (NASDAQ:MBRX) Receives New Coverage from Analysts at StockNews.com

Ticker Report Analysts at StockNews.com began coverage on shares of Moleculin Biotech (NASDAQ:MBRX - Get Free Report) in a report issued on Sunday. The brokerage set a "sell" rating on the stock. Moleculin Biotech...\n more…